Qi Sun

1.9k total citations · 2 hit papers
55 papers, 1.4k citations indexed

About

Qi Sun is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Qi Sun has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Organic Chemistry, 24 papers in Molecular Biology and 8 papers in Computational Theory and Mathematics. Recurrent topics in Qi Sun's work include Computational Drug Discovery Methods (8 papers), Asymmetric Synthesis and Catalysis (7 papers) and Catalytic C–H Functionalization Methods (6 papers). Qi Sun is often cited by papers focused on Computational Drug Discovery Methods (8 papers), Asymmetric Synthesis and Catalysis (7 papers) and Catalytic C–H Functionalization Methods (6 papers). Qi Sun collaborates with scholars based in China, Thailand and France. Qi Sun's co-authors include Luhua Lai, Hao Liang, Baoying Huang, Chunmei Li, Wenjie Tan, Roujian Lu, Hongbo Liu, Hao Ruan, Fei Ye and Siyang Li and has published in prestigious journals such as Chemical Reviews, Nature Communications and ACS Nano.

In The Last Decade

Qi Sun

52 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice

2020 284 citations Qi Sun et al. profile →
Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro

2021 228 citations Hongbo Liu, Fei Ye et al. Journal of Enzyme Inhibition and Medicinal Chemistry profile →

Peers

Countries citing papers authored by Qi Sun

Since Specialization

Citations

This map shows the geographic impact of Qi Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Sun more than expected).

Fields of papers citing papers by Qi Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Sun. The network helps show where Qi Sun may publish in the future.

Co-authorship network of co-authors of Qi Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Sun. A scholar is included among the top collaborators of Qi Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Sun. Qi Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Computer-Aided Drug Discovery for Undruggable Targets 2025 ·Chemical Reviews ·Qi Sun, (unknown), (unknown), (unknown), (unknown), (unknown), Yuhao Ren, Luhua Lai	4
2	Accelerating discovery of bioactive ligands with pharmacophore-informed generative models 2025 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), Yuhao Ren, Jin Xie, Qi Sun, (unknown), Luhua Lai, Jianfeng Pei	7
3	Research progress on the role of microbiota in the pathogenesis of gallstone disease 2025 ·Frontiers in Microbiology ·(unknown), (unknown), (unknown), Qi Sun, (unknown), Liang Lu	0
4	Single atom engineering for radiotherapy-activated immune agonist prodrugs 2025 ·Nature Communications ·Zexuan Ding, Xiaozhe Yin, (unknown), Yiyan Li, (unknown), (unknown), Ziyang Wang, Simiao Qiao, Qi Sun, Fulong Yu, Z. L. Hou, Yang‐Xin Fu, Zhibo Liu	3
5	Characterizing authoritative oncology-related key opinion leaders on Weibo: A social media profiling study 2025 ·Asia-Pacific Journal of Oncology Nursing ·(unknown), Yi Chen, Qi Sun, Jialin Chen, Jiaojiao Zhang, (unknown), Tingting Cai, Changrong Yuan	1
6	Region-confined electrochemical float machining with conductive compliant tool 2025 ·Journal of Materials Processing Technology ·Jingyuan Wang, (unknown), (unknown), (unknown), Qi Sun, Bing‐Feng Ju, Wu-Le Zhu	0
7	Reinforced Immunogenic Endoplasmic Reticulum Stress and Oxidative Stress via an Orchestrated Nanophotoinducer to Boost Cancer Photoimmunotherapy 2024 ·ACS Nano ·Zhenzhen Yang, (unknown), Meng Lin, Yiwei Peng, Yitian Du, Qi Sun, (unknown), Quan Yuan, Yu Zhou, Yiliang Yang, Jiajia Li, Yanxia Zhou, Xinru Li, Xian Qi	17
8	Visualizing single-molecule conformational transition and binding dynamics of intrinsically disordered proteins 2023 ·Nature Communications ·Wenzhe Liu, Limin Chen, (unknown), (unknown), (unknown), Qi Sun, Luhua Lai, Xuefeng Guo	15
9	Discovery of 3-oxo-1,2,3,4-tetrahydropyrido[1,2-a]pyrazin derivatives as SARS-CoV-2 main protease inhibitors through virtual screening and biological evaluation 2023 ·Bioorganic & Medicinal Chemistry Letters ·Xiaodong Dou, Qi Sun, Yameng Liu, (unknown), Caifang Zhang, Guofeng Xu, (unknown), (unknown), Xinyi Zhao, (unknown), (unknown), Luhua Lai, Ning Jiao	1
10	Bionic immunoactivator copresenting autophagy promoting and costimulatory molecules for synergistic cancer immunotherapy 2023 ·Nano Research ·Yiwei Peng, Yiliang Yang, Zhenzhen Yang, (unknown), Jiajia Li, Qi Sun, Yitian Du, Meng Lin, Xian Qi	2
11	Discovery of novel SARS-CoV-2 3CL protease covalent inhibitors using deep learning-based screen 2022 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Shiwei Wang, Zheng Guo, Qi Sun, Luhua Lai	13
12	Discovery of 2-(furan-2-ylmethylene)hydrazine-1-carbothioamide derivatives as novel inhibitors of SARS-CoV-2 main protease 2022 ·European Journal of Medicinal Chemistry ·Xiaodong Dou, Qi Sun, Guofeng Xu, Yameng Liu, Caifang Zhang, (unknown), (unknown), Zheng Guo, (unknown), (unknown), Xinyi Zhao, Chen Wang, (unknown), Song Song, Liangren Zhang, Zhenming Liu, Luhua Lai, Ning Jiao	8
13	Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro breakdown → 2021 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Hongbo Liu, Fei Ye, Qi Sun, Hao Liang, Chunmei Li, Siyang Li, Roujian Lu, Baoying Huang, Wenjie Tan, Luhua Lai	228
14	A transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2 2021 ·Briefings in Bioinformatics ·Shiwei Wang, Qi Sun, Youjun Xu, Jianfeng Pei, Luhua Lai	37
15	Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease 2021 ·Signal Transduction and Targeted Therapy ·Qi Sun, Fei Ye, Hao Liang, Hongbo Liu, Chunmei Li, Roujian Lu, Baoying Huang, Li Zhao, Wenjie Tan, Luhua Lai	41
16	Phototherapy and anti-GITR antibody-based therapy synergistically reinvigorate immunogenic cell death and reject established cancers 2021 ·Biomaterials ·Qi Sun, Zhenzhen Yang, Meng Lin, Yiwei Peng, (unknown), Yitian Du, Yu Zhou, Jiajia Li, Xian Qi	50
17	Albumin-Based Nanotheranostic Probe with Hypoxia Alleviating Potentiates Synchronous Multimodal Imaging and Phototherapy for Glioma 2020 ·ACS Nano ·Zhenzhen Yang, Yitian Du, Qi Sun, Yiwei Peng, (unknown), Yu Zhou, Yuqi Wang, Chunli Zhang, Xian Qi	111
18	Design, synthesis and biological evaluation of quinazoline–phosphoramidate mustard conjugates as anticancer drugs 2017 ·European Journal of Medicinal Chemistry ·Songwen Lin, Yingbo Li, Yufen Zheng, (unknown), Qi Sun, Zemei Ge, Tieming Cheng, Runtao Li	16
19	Development of novel proteasome inhibitors based on phthalazinone scaffold 2016 ·Bioorganic & Medicinal Chemistry Letters ·Lingfei Yang, Wei Wang, Qi Sun, Fengrong Xu, Yan Niu, (unknown), Lei Liang, Ping Xu	17
20	The expression of matrix metalloproteinases in the lung of the rats with vibrio vulnificus sepsis and the intervention of Xuebijing injection 2011 ·Zhonghua jizhen yixue zazhi ·Qi Sun, (unknown), Luming Tang, Zhongqiu Lu, Guangliang Hong, Qiao-meng Qiu, Huan Liang	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact